ML20255A045

From kanterella
Jump to navigation Jump to search
Enclosure 5 - Final Safety Analysis Report, Chapter 16, Other License Considerations
ML20255A045
Person / Time
Site: SHINE Medical Technologies
Issue date: 08/28/2020
From:
SHINE Medical Technologies
To:
Office of Nuclear Reactor Regulation
Shared Package
ML20255A026 List:
References
2020-SMT-0081
Download: ML20255A045 (6)


Text

Chapter 16 - Other License Considerations Table of Contents CHAPTER 16 OTHER LICENSE CONSIDERATIONS TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 16-i Rev. 0 16.1 PRIOR USE OF FACILITY COMPONENTS....................................................... 16.1-1 16.2 MEDICAL USE OF THE FACILITY..................................................................... 16.2-1

Chapter 16 - Other License Considerations List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 16-ii Rev. 0 None

Chapter 16 - Other License Considerations List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 16-iii Rev. 0 None

Chapter 16 - Other License Considerations Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 16-iY Rev. 0 None

Chapter 16 - Other License Considerations Prior Use of Facility Components SHINE Medical Technologies 16.1-1 Rev. 0 CHAPTER 16 - OTHER LICENSE CONSIDERATIONS 16.1 PRIOR USE OF FACILITY COMPONENTS The SHINE facility utilizes new and appropriately-qualified components and systems to conduct production operations. Discussions regarding used components and systems are not applicable to the SHINE facility.

Chapter 16 - Other License Considerations Medical Use of the Facility SHINE Medical Technologies 16.2-1 Rev. 0 16.2 MEDICAL USE OF THE FACILITY The SHINE facility does not contain equipment or facilities associated with direct medical administration of radioisotopes or other radiation-based therapies. Therefore, discussions involving medical use of the SHINE facility are not applicable.